Conclusion
Patients with CHD have significantly increased cancer risk, particularly hematologic, CNS,
and head and neck malignancies. Physicians who care for patients with CHD should be
aware of their predisposition to malignancy after the diagnosis of CHD. Further studies are
warranted to clarify the association between CHD and malignancies.